Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy

Vaccine

Volumn 31, Issue 41, 2013, Pages 4624-4631

  Tchilian, Elma ^a   Ahuja, Diksha ^a   Hey, Ariann ^a   Jiang, Shisong ^b   Beverley, Peter ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Adenovirus; Antigen 85A; Epitopes; Subunit vaccine; Tuberculosis

Indexed keywords

ADENOVIRUS VECTOR; BCG VACCINE; CD4 ANTIGEN; CD8 ANTIGEN; EPITOPE; MYCOBACTERIUM ANTIGEN; MYCOBACTERIUM TUBERCULOSIS ANTIGEN 85A; OVERLAPPING 15MER PEPTIDE ANTIGEN 85A; RECOMBINANT ANTIGEN; RECOMBINANT MYCOBACTERIUM TUBERCULOSIS ANTIGEN 85A; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; BCG VACCINATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; MEMORY CELL; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SPLEEN LYMPHOCYTE; T LYMPHOCYTE;

ADENOVIRUS; ANTIGEN 85A; EPITOPES; SUBUNIT VACCINE; TUBERCULOSIS;

ACYLTRANSFERASES; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGENS, BACTERIAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; EPITOPES, T-LYMPHOCYTE; FEMALE; MICE; MICE, INBRED BALB C; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; TUBERCULOSIS VACCINES; VACCINES, SUBUNIT; VACCINES, SYNTHETIC;

EID: 84883598361     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.07.040     Document Type: Article

References (31)

1. Brennan M.J., Clagett B., Fitzgerald H., Chen V., Williams A., Izzo A.A., et al. Preclinical evidence for implementing a prime-boost vaccine strategy for tuberculosis. Vaccine 2012, 30:2811-2823.
2. Launois P., DeLeys R., Niang M.N., Drowart A., Andrien M., Dierckx P., et al. T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy. Infection and Immunity 1994, 62:3679-3687.
3. Goonetilleke N.P., McShane H., Hannan C.M., Anderson R.J., Brookes R.H., Hill A.V. Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara. Journal of Immunology 2003, 171:1602-1609.
4. Radosevic K., Wieland C.W., Rodriguez A., Weverling G.J., Mintardjo R., Gillissen G., et al. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon. Infection and Immunity 2007, 75:4105-40115.
5. Lin P.L., Dietrich J., Tan E., Abalos R.M., Burgos J., Bigbee C., et al. The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection. Journal of Clinical Investigation 2012, 122:303-314.
6. Forbes E.K., Sander C., Ronan E.O., McShane H., Hill A.V., Beverley P.C., et al. Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice. Journal of Immunology 2008, 181:4955-4964.
7. Wang J., Thorson L., Stokes R.W., Santosuosso M., Huygen K., Zganiacz A., et al. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis. Journal of Immunology 2004, 173:6357-6365.
8. Lee L.N., Ronan E.O., de Lara C., Franken K.L., Ottenhoff T.H., Tchilian E.Z., et al. CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosis. Infection and Immunity 2013, 201(79):3328-3337.
9. Ronan E.O., Lee L.N., Beverley P.C., Tchilian E.Z. Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium tuberculosis after infection. PLoS ONE 2009, 4:e8235.
10. Tchilian E.Z., Ronan E.O., de Lara C., Lee L.N., Franken K.L., Vordermeier M.H., et al. Simultaneous immunization against tuberculosis. PLoS ONE 2011, 6:e27477.
11. Jeyanathan M., Mu J., McCormick S., Damjanovic D., Small C.L., Shaler C.R., et al. Murine airway luminal anti-tuberculosis memory CD8T cells by mucosal immunization are maintained via antigen-driven in situ proliferation, independent of peripheral T cell recruitment. American Journal of Respiratory and Critical Care Medicine 2010, 181:862-872.
12. Gopal R., Rangel-Moreno J., Slight S., Lin Y., Nawar H.F., Fallert Junecko B.A., et al. Interleukin-17-dependent CXCL13 mediates mucosal vaccine-induced immunity against tuberculosis. Mucosal Immunology 2013, 9:2-13.
13. Aranday Cortes E., Kaveh D., Nunez-Garcia J., Hogarth P.J., Vordermeier H.M. Mycobacterium bovis-BCG vaccination induces specific pulmonary transcriptome biosignatures in mice. PLoS ONE 2010, 5:e11319.
14. Jeyanathan M., Damjanovic D., Shaler C.R., Lai R., Wortzman M., Yin C., et al. Differentially imprinted innate immunity by mucosal boost vaccination determines antituberculosis immune protective outcomes, independent of T-cell immunity. Mucosal Immunology 2012, 7(November):103.
15. Franken K.L., Hiemstra H.S., van Meijgaarden K.E., Subronto Y., den Hartigh J., Ottenhoff T.H., et al. Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent. Protein Expression and Purification 2000, 18:95-99.
16. Bennekov T., Dietrich J., Rosenkrands I., Stryhn A., Doherty T.M., Andersen P. Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis. European Journal of Immunology 2006, 36:3346-3355.
17. Billeskov R., Elvang T.T., Andersen P.L., Dietrich J. The HyVac4 subunit vaccine efficiently boosts BCG-primed anti-mycobacterial protective immunity. PLoS ONE 2012, e39909.
18. Zhang H., Hong H., Li D., Ma S., Di Y., Stoten A., et al. Comparing pooled peptides with intact protein for accessing cross-presentation pathways for protective CD8+ and CD4+ T cells. Journal of Biological Chemistry 2009, 284:9184-9191.
19. Denis O., Tanghe A., Palfliet K., Jurion F., van den Berg T.P., Vanonckelen A., et al. Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. Infection and Immunity 1998, 66:1527-1533.
20. McNeil S.E., Rosenkrands I., Agger E.M., Andersen P., Perrie Y. Subunit vaccines: distearoylphosphatidylcholine-based liposomes entrapping antigen offer a neutral alternative to dimethyldioctadecylammonium-based cationic liposomes as an adjuvant delivery system. Journal of Pharmaceutical Sciences 2011, 100:1856-1865.
21. D'Souza S., Rosseels V., Romano M., Tanghe A., Denis O., Jurion F., et al. Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis. Infection and Immunity 2003, 71:483-493.
22. Baldwin S.L., D'Souza C.D., Orme I.M., Liu M.A., Huygen K., Denis O., et al. Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A. Tubercle and Lung Disease 1999, 79:251-259.
23. Hansen S.G., Sacha J.B., Hughes C.M., Ford J.C., Burwitz B.J., Scholz I., et al. Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms. Science 2013, 340. [epub 1237874].
24. Shedlock D.J., Shen H. Requirement for CD4T cell help in generating functional CD8T cell memory. Science 2003, 300:337-339.
25. Sun J.C., Bevan M.J. Defective CD8T cell memory following acute infection without CD4T cell help. Science 2003, 339-342.
26. Comas I., Chakravartti J., Small P.M., Galagan J., Niemann S., Kremer K., et al. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nature Genetics 2010, 42:498-503.
27. Tameris M.D., Hatherill M., Landry B.S., Scriba T.J., Snowden M.A., Lockhart S., et al. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet 2013, 6736:60177-60184.
28. Cohn M.L., Davis C.L., Middlebrook G. Airborne immunization against tuberculosis. Science 1958, 128:1282-1283.
29. Barclay W.R., Busey W.M., Dalgard D.W., Good R.C., Janicki B.W., Kasik J.E., et al. Protection of monkeys against airborne tuberculosis by aerosol vaccination with bacillus Calmette-Guerin. American Review of Respiratory Disease 1973, 107:351-358.
30. Buddle B.M., Keen D., Thomson A., Jowett G., McCarthy A.R., Heslop J., et al. Protection of cattle from bovine tuberculosis by vaccination with BCG by the respiratory or subcutaneous route, but not by vaccination with killed Mycobacterium vaccae. Research in Veterinary Science 1995, 59:10-16.
31. Song K., Bolton D.L., Wei C.J., Wilson R.L., Camp J.V., Bao S., et al. Genetic immunization in the lung induces potent local and systemic immune responses. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:22213-22218.